Fermata Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$629K Buy
524
+132
+34% +$135K 0.13% 134
2026
Q1
$361K Buy
392
+136
+53% +$138K 0.08% 163
2025
Q4
$275K Sell
256
-6
-2% -$5.74K 0.07% 177
2025
Q3
$200K Sell
262
-179
-41% -$133K 0.05% 204
2025
Q2
$344K Sell
441
-810
-65% -$629K 0.09% 165
2025
Q1
$1.03M Buy
1,251
+338
+37% +$281K 0.19% 103
2024
Q4
$705K Sell
913
-351
-28% -$291K 0.13% 110
2024
Q3
$1.12M Buy
1,264
+29
+2% +$26.1K 0.23% 76
2024
Q2
$1.12M Buy
1,235
+122
+11% +$97.6K 0.26% 72
2024
Q1
$866K Buy
1,113
+242
+28% +$172K 0.2% 87
2023
Q4
$508K Buy
871
+12
+1% +$7K 0.12% 104
2023
Q3
$463K Buy
+859
New +$443K 0.13% 101
2023
Q1
Sell
-860
Closed -$316K 120
2022
Q4
$316K Sell
860
-30
-3% -$10.6K 0.09% 110
2022
Q3
$289K Sell
890
-273
-23% -$86.5K 0.09% 116
2022
Q2
$379K Sell
1,163
-358
-24% -$107K 0.13% 115
2022
Q1
$437K Sell
1,521
-148
-9% -$38.1K 0.16% 101
2021
Q4
$462K Buy
1,669
+50
+3% +$12.7K 0.17% 95
2021
Q3
$374K Buy
1,619
+93
+6% +$23K 0.17% 101
2021
Q2
$351K Buy
+1,526
New +$307K 0.2% 88

Other funds holding LLY

Fermata Advisors's LLY Position: Q2 2026 in Review

Fermata Advisors increased its Eli Lilly (LLY) stake by 34% in Q2 2026, buying an estimated $135K and bringing the position to 524 shares worth $629K. The position accounts for 0.13% of the portfolio, ranked #134.

Fermata Advisors first reported a position in LLY in Q2 2021 and has held it in 19 quarters since. The position peaked at $1.12M in Q3 2024. 767 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fermata Advisors held 524 shares of Eli Lilly worth $629K as of Q2 2026.
  • Fermata Advisors bought 132 Eli Lilly shares in Q2 2026, an estimated $135K.
  • Eli Lilly made up 0.13% of Fermata Advisors's portfolio in Q2 2026, its #134 holding.
  • Fermata Advisors first reported a position in Eli Lilly in Q2 2021 and has held it in 19 quarters since.
  • Fermata Advisors's Eli Lilly position peaked at $1.12M in Q3 2024.
  • 767 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fermata Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.